Few large employers cover GLP-1 weight-loss drugs
Published
Only 18% of large firms cover drugs like Wegovy and Zepbound for weight loss, often with limits, KFF reports. Only about 1 in 7 firms that don't cover them say they're likely to start within a year. Check your plan's drug list before you count on coverage.
Source: KFF
This is a plain-language summary. Read the original source for full details.